Brief: CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee Recommendation
28/01/2026 12:05
Jan 28 (Reuters) - CalciMedica Inc CALC.O: CALCIMEDICA ANNOUNCES DISCONTINUATION OF PHASE 2 KOURAGE TRIAL IN AKI FOLLOWING INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDATION CALCIMEDICA INC: SAFETY CONCERN WARRANTS REEVALUATION OF STUDY DESIGN, INCLUDING ENROLLMENT CRITERIA CALCIMEDICA INC: POTENTIAL FUTURE TRIAL WITH AUXORA IN AKI TO BE EVALUATED AFTER DATA ANALYSIS CALCIMEDICA INC - IDMC IDENTIFIES SAFETY CONCERN IN STUDY DESIGN CALCIMEDICA INC: THERE WERE NO DEATHS IN TRIAL THAT WERE ASSESSED BY INVESTIGATORS OR CALCIMEDICA AS BEING RELATED TO STUDY DRUG Source text: ID:nPn79FFBZa Further company coverage: CALC.O ((Reuters.Briefs@thomsonreuters.com;))